Previous studies have well characterized the dysfunction of ENTPD3 in human Parkinson’s disease [67], Alzheimer’s disease [68], and Crohn’s disease [69]. This evidence concerns the gene ENTPD3 and early-onset autosomal dominant Alzheimer disease.